Travere Therapeutics (TVTX) Earnings Date, Estimates & Call Transcripts $19.43 -0.03 (-0.13%) As of 02:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Travere Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 20Before Market OpensEstimatedActual EPS (Oct. 31) -$0.70 Beat By $0.01 Consensus EPS (Oct. 31) -$0.71 Travere Therapeutics posted Q3 2024 earnings on October 31, 2024, reporting an EPS of -$0.70, which topped analysts' consensus estimates of -$0.71 by $0.01. Quarterly revenue rose 69.6% year-over-year to $62.90 million, above the consensus estimate of $60.87 million. With a trailing EPS of -$4.55, Travere Therapeutics' earnings are expected to grow next year, from ($3.93) to ($1.27) per share. Conference CallConference Call TranscriptSEC 10-Q/10-K FilingTVTX Upcoming EarningsTravere Therapeutics' next earnings date is estimated for Thursday, February 20, 2025, based off prior year's reporting schedules. Get Travere Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Travere Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TVTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Travere Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.59-$0.34-$0.45Q2 20253-$0.43-$0.10-$0.26Q3 20253-$0.34$0.27-$0.09Q4 20253-$0.04$0.54$0.27FY 202512($1.40)$0.37($0.53) Travere Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/20/2025(Estimated)-------10/31/2024Q3 2024-$0.71-$0.70+$0.01-$0.70$60.87M$62.90M8/1/2024Q2 2024-$0.87-$0.90 -$0.03-$0.89$49.50M$54.12M5/6/2024Q1 2024-$0.98-$1.76 -$0.78-$1.76$43.46M$41.40M2/15/2024Q4 2023-$1.27-$1.16+$0.11-$1.14$41.25M$45.06M11/7/2023Q3 2023-$1.09-$1.17 -$0.08-$4.31$132.01M$37.10M8/3/2023Q2 2023-$1.16-$1.13+$0.03-$1.13$53.93M$59.70M5/4/2023Q1 2023-$1.18-$1.27 -$0.09-$1.27$50.93M$56.99M2/23/2023Q4 2022-$1.04-$1.03+$0.01-$1.03$54.80M$55.87M Travere Therapeutics Earnings - Frequently Asked Questions When is Travere Therapeutics's earnings date? Travere Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates. Learn more on TVTX's earnings history. Did Travere Therapeutics beat their earnings estimates last quarter? In the previous quarter, Travere Therapeutics (NASDAQ:TVTX) reported ($0.70) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.71) by $0.01. Learn more on analysts' earnings estimate vs. TVTX's actual earnings. How can I listen to Travere Therapeutics's earnings conference call? The conference call for Travere Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Travere Therapeutics's conference call transcript? The conference call transcript for Travere Therapeutics's latest earnings report can be read online. Read Transcript How can I view Travere Therapeutics's earnings report? Travere Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Travere Therapeutics generate each year? Travere Therapeutics (NASDAQ:TVTX) has a recorded annual revenue of $203.45 million. How much profit does Travere Therapeutics generate each year? Travere Therapeutics (NASDAQ:TVTX) has a recorded net income of -$111.40 million. TVTX has generated -$4.55 earnings per share over the last four quarters. What is Travere Therapeutics's EPS forecast for next year? Travere Therapeutics's earnings are expected to grow from ($3.93) per share to ($1.27) per share in the next year. More Earnings Resources from MarketBeat Related Companies Cytokinetics Earnings Nuvalent Earnings Grifols Earnings TG Therapeutics Earnings Axsome Therapeutics Earnings Krystal Biotech Earnings Verona Pharma Earnings Organon & Co. Earnings Scholar Rock Earnings Alvotech Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:TVTX) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Travere Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVTX Stock Alerts